Application 208175
- Type
- ANDA
- Sponsor
- DR REDDYS LABS SA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 3.75MG BASE;23MG | No | No |
| 002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 7.5MG BASE;46MG | No | No |
| 003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 11.25MG BASE;69MG | No | No |
| 004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 15MG BASE;92MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208175-001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | |
| A208175-002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | |
| A208175-003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | |
| A208175-004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208175-001 | AB |
| A208175-002 | AB |
| A208175-003 | AB |
| A208175-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208175-001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208175-002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208175-003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208175-004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-001 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-002 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-003 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-004 | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2025-06-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208175-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208175-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208175-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208175-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208175-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208175-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208175-004 | AB | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208175-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phentermine and Topiramate Extended-Release | PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE | Dr.Reddys Laboratories Inc | 260c3f90-163d-0bdd-1099-55d18a900e68 | 2026-03-31 | Warnings, Adverse reactions | 208175 ANDA208175 |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82578 | ORIG | 2025-06-16 |